Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
Fire breaks out at Kuwaiti refinery after drone attacks
US strike against alleged drug smugglers in eastern Pacific kills two
UK says vaccine protects against strain in deadly meningitis outbreak
Tropical Cyclone Narelle weakens after lashing Australia's northeast with winds, rain
More than 50 injured in fire at car parts factory in South Korea
